Monday, May 2, 2022

Medication Guide - 5/2/2022

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Caplyta Lumateperone Tosylate CAPSULE;ORAL 209500 INTRA-CELLULAR 04/22/2022
Fensolvi Kit Leuprolide Acetate POWDER;SUBCUTANEOUS 213150 TOLMAR 04/22/2022
Lupron Depot-Ped Kit Leuprolide Acetate POWDER;INTRAMUSCULAR 020263 ABBVIE ENDOCRINE INC 04/22/2022
Metadate CD Methylphenidate Hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 021259 LANNETT CO INC 04/22/2022
Supprelin LA Histrelin Acetate IMPLANT;SUBCUTANEOUS 022058 ENDO PHARM 04/22/2022
Synarel Nafarelin Acetate SPRAY, METERED;NASAL 019886 PFIZER 04/22/2022
Triptodur Kit Triptorelin Pamoate FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 208956 ARBOR PHARMS LLC 04/22/2022
Jentadueto Linagliptin; METformin Hydrochloride TABLET;ORAL 201281 BOEHRINGER INGELHEIM 04/15/2022
Tradjenta Linagliptin TABLET;ORAL 201280 BOEHRINGER INGELHEIM 04/15/2022
Xigduo XR Dapagliflozin; METformin Hydrochloride TABLET, EXTENDED RELEASE;ORAL 205649 ASTRAZENECA AB 04/11/2022
Ibsrela Tenapanor Hydrochloride TABLET;ORAL 211801 ARDELYX INC 04/05/2022
Solaraze Diclofenac Sodium GEL;TOPICAL 021005 FOUGERA PHARMS 04/05/2022

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment